Bio-Rad Laboratories (BIO) Return on Capital Employed (2010 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Return on Capital Employed of 0.62% for Q1 2026, down 499.0% year-over-year from 0.16% in Q1 2025, and up 26.69% quarter-over-quarter from 0.49% in Q4 2025.
Bio-Rad Laboratories (BIO) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Return on Capital Employed for 17 consecutive years, with 0.62% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 499.0% year-over-year to 0.62%; the TTM figure through Mar 2026 stood at 0.62% (down 499.0% YoY), while the FY2025 annual figure was 0.5%, down 553.0% from the prior year.
- Return on Capital Employed climbed to 0.62% in Q1 2026 per BIO's latest filing, from 0.49% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1221.09% in Q1 2024 and bottomed at 73.98% in Q2 2025.
- Historically, Return on Capital Employed has averaged 80.6% across 5 years, with a median of 5.18% in 2025.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 121471 bps — and 2025, when it plunged 121547 bps.
- Bio-Rad Laboratories' Return on Capital Employed stood at 8.84% in 2022, then plunged by 33 bps to 5.96% in 2023, then gained by 3 bps to 6.16% in 2024, then slumped by 92 bps to 0.49% in 2025, then advanced by 27 bps to 0.62% in 2026.
- Business Quant data shows BIO's Return on Capital Employed at 0.62% in Q1 2026, 0.49% in Q4 2025, and 5.18% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.48 Bn | 123.00 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.22 Bn | 73.68 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.35 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.96 Bn | 33.02 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.21 Bn | 22.89 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 12.08% |
| 10 | Bio-Rad Laboratories | 10.21 Bn | 8.59 Bn | 345.80 Mn | 0.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.59% |
| Mar 31, 2026 | 0.62% |
| Dec 31, 2025 | 0.49% |
| Sep 30, 2025 | 5.18% |
| Jun 30, 2025 | -73.98% |
| Mar 31, 2025 | 5.62% |
| Dec 31, 2024 | 6.16% |
| Mar 31, 2024 | 1,221.09% |
| Dec 31, 2023 | 5.96% |
| Sep 30, 2023 | 3.17% |
| Jun 30, 2023 | 2.98% |
| Mar 31, 2023 | 6.38% |
| Dec 31, 2022 | 8.84% |
| Sep 30, 2022 | 4.08% |
| Jun 30, 2022 | 4.21% |
| Mar 31, 2022 | 8.22% |
| Dec 31, 2021 | 5.32% |
| Sep 30, 2021 | 3.36% |
| Jun 30, 2021 | 3.74% |
| Mar 31, 2021 | 6.92% |